Pati ents with an endo lyniphatic sac tum or!ELS T) typ ically p resent with palsy ofcra nial nerves VII and/or VIII ; ot her presenting symp toms incl ude hearin g loss , otalgia, occipital headach es, cranial ner ve palsies, vertigo , gai t atax ia, tinnitus, and oto rrhea . ELSTs are extreme ly vasc ulat; and they can in vade and destroy temp oral bon e. Becau se of these cha rac te ristics, they are of ten mistak en fo r glom us tum ors ofthe skull base. We describe the clinical presentation , evaluatio n, and managem ent ofEL STs based on our review of the limi ted literature and our experience with 3 adults who presented to our tertiary care referral center with large ELSTs.A lthough these patients present ed late in the course oftheir disease, their sym ptoms were relati vely minor: Preop erative tum or embo lization was perform ed, and a near-complete resection was achi eved via an extended tra nso tic approach in all 3 pati ent s. Th e f acial ner ve was preserved witho ut transposition in the firs t p atient , the second p atie nt unde rwen t a prima ry ner ve anastomosis. and the third required a cable graft of the f aci al ner ve. Postop erative radiation therap y was administered to
Introduction
Endolymphatic sac tumors (ELSTs) are extre mely rare, slowly gro wing, low-grade adenocarcino mas that are associated with von Hippel-Lindau (VHL) disease.Approximately 88 cases of documented ELSThave been previously reported."? Th ese tumors are genera lly considered to be benign on the basis of their histologic characteristics , yet they behave clinically in an aggressive manner. One of the sequelae is temp oral bone destructio n that frequentl y involves the cere bellopo ntine angle and petrou s apex by direct exten sion. ELSTs ca n become quit e extensive before significant symptoms develop. Cran ial nerve involvement is typical. In this article , we describe 3 new cases of ELST. The se tumors were large and exten sive, and they were resected via a transotic craniotomy appro ach following tum or emboliza tio n.
Case reports
Patient 1. A 26-year-old man presented to the emerge ncy room complaining of left-sided otalgia , otorrhea , and hearing loss of 3 months' dur ation. In addition, he had been suffering fro m heada ches, mild gai t ataxia , and occas ional attacks of vertigo. He was in goo d health , he had no history of childhood ear infe ction s or ear surge ry, and he denied head and otologic traum a.
Physic al exa minatio n revealed Hou se-Br ackm ann 10 grade IlIYI left peripheral facial palsy. In addition, the patient had hypoesthesia of the left trigem inal nerve and a severe to profound mixed hearing loss on the left. Bonecondu ction threshold s at 500 , 1,000, 2,000 , and 3,000 Hz averaged 85 dB , and air-condu ction thre shold s sloped from 115 dB .Audi om etry on the right demon strat ed a mild sensorineural hearing loss, with air-and bone-condu ction threshold s at 500, 1,000 , 2,000, and 3,000 Hz averaged at 30 dB. The left externa l auditory ca nal was filled with purul ent debris, which was suctioned and cultured . The tympanic membrane was thickened , and it exhibited a small ( I to 2 mm) posterior perfo ration that was surrounded by granulation tissue .
Computed tom ography (CT) of the temporal bones revealed opacification of the left mastoid and middle ea r.The oss icles were intact. Extensive bone eros ion of the petrous apex extended into the internal auditory ca nal (figure I,A ). Based on this study, a prelimin ary diagnosis of otornastoidit is with osteom yelit is was made. Myrin gotomy was performed, and pul satile clear fluid drained throu gh the defect. The fluid was cultured and examined for glucose and B2-transferrin levels. The patient was admitted to the hospital for intravenous antibiotics (ceftazidime and tobramycin), and he was also treated with ofloxaci n otic drop s. Yet despite antibiotic therapy, the otorrhea failed to abate.
Mag ne tic resonance imaging (MRI) of the temporal bones was perform ed. T I-weighted noncontrast seque nces detected a 5.0 x 4.4 x 4.5-cm multil obul ated mass with heterogenous enha ncement in the left cerebellopo ntine angle (figure I, B).Axial (figure I ,C) and coro nal (figure I, D) gadolinium-enhanced, T l-weighted MRls demonstrated centra l enhanceme nt of the mass, petrou s bone dest ru ct ion , a nd obliteration of the internal auditory canal. Th e tumor mass involved the j ugular fora men inferio rly and extended into the cavernous sinus surro unding the caroti d art er y. The mass extended medially with cere bellar compression. The preopera tive differe ntial diagnosis includ ed glomus tum or (vaga le or j ugulare), men ingioma, ELST, choroi d plexus papill oma, and aneurys mal bone cyst.
Surgic al exc ision with preoperative tumor embolization was planned. Cerebral angiography revealed that the tumor was primarily supplied by three branches of the left exte rna l caro tid artery-the left posterior occ ipital artery, the asce nding pharyngeal artery, and the posterior auricular artery-with a minor contribution from the petrous branch ofthe left internal carot id artery.The contributing branches of the left externa l carotid artery were successfully ernbolized with polyvinyl alcohol. Blood supply to the tumor after embolization was estimated to have been reduced by at least 60%. Within 24 hour s, the patient was taken to surgery, and he underwent a left transotic (translabyrinthine and transcoc hlear) craniotomy for tumor resection.
The procedure involved making a postauricular incision that extended into the neck. The great vesse ls and lower cranial nerves were isolated in the neck and traced back to the skull base. The left externa l auditory canal was closed in two layers, and a blind pouch was created in the manner described by Jackler," Thi s was done to isolate the surgical resection and prevent cerebros pinal fluid leak. Com plete mastoidectom y was performed, and the sigmoid sinus was ske letonized from the lateral sinus to the ju gular bulb below. The tumor was encounte red in the masto id antrum adjacent to the incus. The mass was spongy, reddish-tan to Volume 86, Number 1 brown, and extremely vascular. Findings on frozen-sec tion analysis of its cys tic components were consistent with a glomus tum or.
The mass exte nded posteriorl y to, but did not involve, the sigmoi d sinus lumen. The pre-and postsigmoid dura was skeletonized, and the facia l nerve was completely dissected throughout its intrat emp oral course. The bony coveri ng of the facial nerve was left intact. The decision was made not to transpose the nerve but rather to rem ove the tumor from arou nd the nerve. The tumor had invaded the intern al auditory canal below the superior semicircular canal, and it extended anteriorly to the carotid artery. The tumor 's intracranial component was found to extend along the petrou s ridge to the cavernous sinus anteriorly and to the ju gular foramen inferiorly. The tum or 's posterior fossa com ponent was entirely extradural.
Near-total tumor remova l was acco mplished. Residu al tumor was left along the caro tid artery in the cave rno us sinus, and postoperative radiotherapy was planned . The dural defect was closed with a large autologous fat graft that extended into the mastoid regio n, and the skin was closed in two layers. The total amo unt of blood loss was estimated to be 3,800 ml.
Postoperatively, the patient had grade IIIIVI facial paresis and left voca l fold paresis; the latter was probably caused by extensive dissec tion at the j ugular foramen.The patient was disch arged on postoperative day 7. On postoperative day 15, he was readm itted with a pseudomeningocele at the incision site. He did not have any fever, chills, or meningeal signs.The wound was treated with compressive dressings for 5 days, and the problem resolved.
Final tumor pathology revealed a highly vascular stroma with multiple cystic spaces, foc al calcifications, and a papilla ry architecture (figure 2, A). Individual nonciliated low cuboidal tumor cells had well-defined borders and bland nuclei that were unifo rm in size ( figure 2, B ). Immunohi stochemical stains were positive for cytokeratin, vimentin , neuron-specificenolase, and epithelial membrane antigen . The stain s were negative for thyroglobulin. The final diagno sis was a low-grade papill ary adenocarcinoma consi stent with an ELST.
The patient subsequently underwent radiation therapy to treat the residual tumor that had been left in the cavernous sinus. At the I-year follow-up, he exhibited no radiologic or clinical evidence of residual or recurrent disease. His facial nerve funct ion had returned to its preoperative state (grade II), and his left vocal fold paresi s had completely resolved . A further workup was undertaken to look for evidence of VHL disease-such as retinal hemangioblastoma s, central nervou s system hem angioblastom as, renal cysts, pheochromocytom a, or panc reatic tumors'<e-and no such abnormalities were detected.
Patient 2. A 26-year-old wom an presented with a 3month history of progressive left facial weakness and otalgia. Her history was relev ant for a progressive leftsided hearin g loss with tinnitus, which she attributed to a motor vehicle accident 3 years earlier. Her history was otherwise unrem arkable.
Physical examination revealed grade V left facial nerve palsy. The left eardrum was intact and mobile , but there was a bluish hue behind it, and a red mass could be seen in 32 the hypot ymp anum. The mass did not blanch with insufflation. The right ear was normal. Audiometry reve aled a complete sensorineural hearing loss on the left , with only vibrotactile sensation. Hearin g on the right was norm al with a pure-tone average threshold of 5 dB.
CT of the temporal bone s identified a destructive lesion involving the left mastoid , petrou s apex , and cerebellopontine angle. MRI demon strated a heterogenously enhancing mass of the left cerebellopontine angle that measured approximately 6.4 x 5.7 x 3.0 em. The MRI also detected evide nce of bone destruction and tumor exten sion into the posterior fossa, jugular foramen , and mastoid air cells. A preliminary diagnosi s of glomus tumor was made; the differential diagnosis included ELST and heman giopericytoma.
Preop erative angio graphy revealed that the extremely vascular mass was supplied by branches of the left external carotid artery, includ ing the meningeal branch of the occipital artery, the ascending pharyngeal artery, and the middle menin geal artery. All three of these branche s were successfully embolized with polyvinyl alcohol.
Within 48 hour s of embol ization, the patient was taken to the operatin g room for tumor resecti on . A transotic craniotomy with anterior facial nerve transposition was required. The tum or had invaded the ju gular bulb and encroached on the sigmoid sinus, requi ring sacrifice of those structures . Th e tumor had grossly invaded the facial nerve at the second genu, as well as the vestibulocochle ar nerve at the cerebellopontine angle. Approximately 7 mm of involved facial nerv e was resected , and a primary anastomosis was performed. The VIIIth nerv e was sacrificed. obturate the dural defect. There was no tumor invol vement of the temporal lobe or cere bellum. The total amount of intraoperative blood loss was estimated to be 800 m!.
The patient 's facial paresis progressed to grade VI/VI after surge ry. She did well postoperatively and was discharged home on postoperative day 7.The final pathologic diagnosis was ELST; perm anent sections showed hemorrhagic stro ma with pap illary frond s covered by columnar epithelium ( figure 3 ). In view of this diagnosis, abdominal CT was performed to look for ev idence of VHL disease, and none was found . The patient then received 4,500 cOy of externa l-beam irradiation to the tumor bed without consequence. Her faci al nerve function improved to grade IV. At the 3-yea r follow-up, she remained free of disease.
Patient 3. An otherwise-h ealth y, 54-year-old woman presented to the otolaryngo logy clin ic complaining of an I I-month history of right-sided hearing loss and tinnitu s. She denied otalgia, otorrhea, vertigo, headache , or weig ht loss. Her medical history was significant only for a motor vehicle accident 1year earlier, which had preceded the onset of her sy mptoms by approx ima tely I month . Her fam ily history and review of systems were noncont ributory.
Physical exa mination revealed right-sided cra nial nerve VIII dys function, which was evident on tuning-fork testing and audio metry. The patient' s facial functio n was gra de I. Findin gs on inspection of the ear were normal exce pt for a bluish hue in the right middl e ear space. Tympanometry revealed normal mobility bilaterally.Audio metry reflected a profound sensorineural hearing loss on the right, with no response at 100 dB. The pure-tone average air-conduction threshold on the left was 12 dB.
CT of the temp oral bones revealed a destructive lesion of the right petrou s apex, and MRI showed a 3. 
. Tumor section exhibits the papillaryfronds lined with uniform ciliated loll'cuboidal cells.fo am cells, and p igment ed cytoplasmic granules (ori ginal magnification x400)
2.8-cm heterogenou sly enhancing mass ofthe right petrous apex.The results of a mamm ogram and CT of the abdo men and pelvis were norma!. A preliminary diagnosis of ELST versus glomus tumor was made.
Preoperat ively, successful embolization of the tumor 's blood supply from branches ofthe right postauricular artery, the asce nding pharyngeal artery, and a posterior branch of the right middl e menin geal artery was performed .
Th e followin g mornin g, the patient underwent tumor resection via a right transotic craniotomy. The tumor had filled the middle ear space, and it appeared to have arisen from the medial wall of the tympanic cavity. The mass surrounded the stapes and involved the facial nerve. The facial nerv e was skeletonized and transposed anteriorly. The involved facia l nerve was resected and cable-grafted with the right great auricular nerve. Th e tumor was found to have invaded the cochlea and most of the labyrinth. Intracrani ally, the tumor extended inferiorly along the temp oral bone, requiring a delic ate dissecti on of the lower cra nial nerves (IX, X, and XI). The tumor had also invaded the posterior fossa dura, which was resected and grafte d with rectus abdominus fascia. Findings on intraoperative frozen -sec tion analysis were consistent with an ELST. Near-total tumor remova l was achieve d. The estimated total amount of intraoperative blood loss was 1,800 m!.
Final pathology confirmed that the tum or was an adenocarcinoma of endolymphatic sac origin. Foam cells (i.e., macroph ages with vacuolated cytoplas m) with pigmented cytoplasmic granules, presumably containing hemosiderin, were abundant within papill ary fronds , which were lined with ciliated low cuboidal epithelium ( figure 4) .
Postoperatively, the patient exhibited dysphagia, hoarseness, and grade VI right facial palsy. Flex ible laryngo scopy performed at the bedside revealed paralysi s of the right true vocal fold. A swallowing evaluation did not demonstrate aspiration, and the patient was able to tolerate a thin dysphagia diet. Appropriate eye care was also initiated.
One week postoperatively, the patien t underwent impla ntatio n of a gol d wei ght in the righ t upper eye lid to facilita te eye closure and pro tect the co rnea. In addition, she recei ved an injectio n of autologous fat into the right vocal fold to improve vocaliza tion . Her voice imp roved notabl y, and she was discharged fro m the hospital on the fo llow ing day. A workup for VHL disease was negati ve.
The patient was scheduled to und ergo postop erative radiotherapy, but she refu sed any furth er treatment. Within 6 months, her right facia l palsy improved to grade IV, and the go ld weight was subse que ntly rem oved from her right upper eyelid. Alth ou gh her rig ht vocal fold function had not improved, she refu sed mediali zation thyropl asty. At 4 years postope rative ly, she rem ained free of disease.
Discussion
The ELST was first rep orted by Trei tel in 1898 as an adenocarcinoma of the midd le ear," Nearly a ce ntury later, Heffner correctly described the entity as a lowgrade ade nocarcinoma and recog nized its origi n as the endoly mphatic sac ."
Th e endo lympha tic sac lies between the petrou s periosteu m and the posteri or fossa dura , near the sigmoid sinus andj ugular bulb , and posterior to the internal auditory ca nal. Its put ati ve functio n is to regul ate endolymphatic pressu re, fluid vo lume, and ion ic balance within the inner ear. 15 • 16 ELSTs are neu roectoderm al tumors that are believed to arise fro m the pro xim al, rugose portion of the endolymphatic sac, which is intratemporal, as opposed to the distal porti on of the sac, which lies adjacent to the du ra.' >" Sign s and symptoms. ELSTs usually present in the third and fou rth decades of life, and there is a slight female prepond erance. " Patient s may present with hearing loss, otalgia, occ ipital headaches, cra nial nerve pa lsies, vertigo , gait atax ia, tinn itus, and otorrhea . Crania l nerve invol vement is usua lly limit ed to the vestibulocochlear and faci al nerve s, but trige minal and abduce ns nerve pa lsies have also been reported.18O ur pa tient I pre se nted with a trigeminal nerve abnorma lity. Gait ataxi a may indicate cerebellar co mpression, usua lly cau sed by a large tumor.
Otorrhea is an unusual pre sen ting symptom in patien ts with EL ST, but whe n it do es occ ur, it may indica te (I ) eustachian tub e dysfun ction cau sed by either direct tumor involvem ent or compressio n or (2) a destr uctive process invo lving the middle ear and/o r ma sto id. A delay in diag nosis may occ ur if the patient is mistakenl y diagn osed with chro nic otitis media. '?Jugul ar fora me n sy ndro me has also been rep orted. tv' ?
Pathogenesis. ELST is stro ng ly assoc iated with VHL 34 disease , a hereditary cancer syndrome.12.20-22 Mu tatio n of the VHL ge ne within ELST cells has been de mo nstrate d in patients who have no other man ife stations of VHL disea se, which suggests that somatic mu tation of the gene is an inciting factor in tumorigenesis.w" ?'
The VHL ge ne is a tum or suppre ssor tha t reg ulates extrace llular matrix for ma tion, the ce ll cycle, and transcription of vascular endo the lia l growth factor, a proto-oncogene that prom otes angiogenesis.i' :" Wh en the VHL gene is inactivated by deleti on or mut ation , vasc ular end otheli al gro wth fac tor is unregulated and ove rex pressed, resulting in the development of the vascul ar tum ors that are typic al ofVHL disease. The most co mmo n manifestations ofVHL d isease are retin al hem angiobl astom as, central ner vou s system hem angioblastom as, and visce ral tum ors. "
Th e VHL ge ne is locat ed at 3p25.5, and ge netic testin g for co mmo n mut ati on s is now ava ilable." Becau se ELST may be a mani festat ion ofVHL, pa tie nts with documented ELSTs should undergo a workup for VHL disea se . Speci fica lly, an abdominal CT and a thoroug h retina l exami natio n are indicated. also, intr atumoral bon e is evi de nt in many cases." MRI typi cally reveals a heterogenou s mass wi th hypo-, hyper-, and iso intense foci on TI -and T 2-weight ing and var iable enha nce me nt with con trast."
Histologically, ELSTs have a benign appea rance, displaying hem orrha gic, highl y vasc ularize d stro ma with cys tic spaces and focal calcifications. Cell s fo rm a papillary architecture, with individua l ce lls havin g well -defined bord ers and bland nucl ei (uniformly round and sma ll to medium in size). Ce lls may vary betw een cilia ted or non cili ated and co lumnar or low cuboi dal, as was see n in all 3 cases presented here. Foam ce lls with vac uolated cy toplasm may be present , and they often have pigm ent ed cy toplas mic gra nules co ntaining hemosiderin.P:"
Treatment. Surgical resection is the treatme nt of cho ice .
Th e type of surgical approach is dictated by the locatio n and exte nt of the tu mor and the patient's preoperative functional deficit s. Ofthe previou sly reported ca ses1-9of docume nted ELST, preo perative embo liza tion was performed in on ly 2,29and in both ca ses, it was found to be be nefic ial in limi ting the amount of intr aop erative blood loss. Em bolization was performed in all 3 of the cases descr ibed in this article , and it was successful in all of them .
Resecti on of ELSTs has been performed via a variety of neu rotologic and skull base approaches, including retros igmoid, suboccipital, transcochl ear, tran spetrosal, tran sl ab yrinthine, and tr an sm ast oid craniotomy ap- proaches. U-!' Large tumors with anterior and inferior extension approac hing the clivus and ju gular fora men, respectively, typically requi re an exten ded transcochlear approach, including facial nerve transposition. I I Rerouting of the facial nerve usuall y results in total but transient postoperative facial palsy; the palsy generally resolves in 6 to 12 month s, but the resulting synki nesis and asym metry may not. Furth ermore, posterior transposition requi res seve ring the chorda tympani and grea ter superficia l petrosa l nerves, which results in transient dysgeusia and an ipsilateral dry eye. I I Our patient I underwent a successful transotic resection without the need for facial nerve rerouting or transposition.
The indications for postoperative radiation therapy are still controve rsial.Although 50% efficacy has been reported for the treatment of ELST with rad iotherapy alone, a 90% cure rate has been reported for com plete ELST exc ision without radiation.14 The newer stereotactic radios urgery modalities such as the ga mma knife and cyberknife need to be considered as adj uncts to surgical therapy. The paucity of cases in which treatment modalities and outcomes were reported makes the decision difficult. In the 3 cases reported here, extensi ve tumor involvement preclu ded complete microscopic tumor remov al, and postoperative radio therapy was recomm ended in all 3 cases. Further studies are needed to inves tigate the role of postoperat ive radia tion in ELST because local recurrences are problematic. No case of metastasis has been reported.
